- Home
- JDZG vs NCNA Comparison
JDZG vs NCNA Comparison
Compare JDZG & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- NCNA
- Stock Information
- Founded
- JDZG 2020
- NCNA 1997
- Country
- JDZG China
- NCNA United Kingdom
- Employees
- JDZG N/A
- NCNA N/A
- Industry
- JDZG Other Consumer Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- NCNA Health Care
- Exchange
- JDZG Nasdaq
- NCNA Nasdaq
- Market Cap
- JDZG 5.7M
- NCNA 6.6M
- IPO Year
- JDZG 2024
- NCNA 2017
- Fundamental
- Price
- JDZG $1.70
- NCNA $2.88
- Analyst Decision
- JDZG
- NCNA
- Analyst Count
- JDZG 0
- NCNA 0
- Target Price
- JDZG N/A
- NCNA N/A
- AVG Volume (30 Days)
- JDZG 129.9K
- NCNA 483.1K
- Earning Date
- JDZG 04-25-2025
- NCNA 08-20-2025
- Dividend Yield
- JDZG N/A
- NCNA N/A
- EPS Growth
- JDZG N/A
- NCNA N/A
- EPS
- JDZG 0.25
- NCNA N/A
- Revenue
- JDZG $2,567,741.00
- NCNA N/A
- Revenue This Year
- JDZG N/A
- NCNA N/A
- Revenue Next Year
- JDZG N/A
- NCNA N/A
- P/E Ratio
- JDZG $7.03
- NCNA N/A
- Revenue Growth
- JDZG 20.36
- NCNA N/A
- 52 Week Low
- JDZG $1.58
- NCNA $2.78
- 52 Week High
- JDZG $21.28
- NCNA $1,650.00
- Technical
- Relative Strength Index (RSI)
- JDZG 38.83
- NCNA 29.01
- Support Level
- JDZG $1.71
- NCNA $2.78
- Resistance Level
- JDZG $2.13
- NCNA $3.60
- Average True Range (ATR)
- JDZG 0.15
- NCNA 0.27
- MACD
- JDZG 0.02
- NCNA 0.32
- Stochastic Oscillator
- JDZG 10.40
- NCNA 6.43
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.